No more crystal balls

pharmafile | February 6, 2008 | Feature | Sales and Marketing |  forecasts, sales 

Related Content

Exscientia buys Austrian cancer cell screening company for €50 million

UK-based AI pioneers Exscientia has announced the purchase of rival AI firm Allcyte for €50 …

Deloitte acquires Iperion Life Sciences Consultancy

Deloitte have announced the acquisition of Iperion Life Sciences Consultancy, a globally-operating firm working to …

novartis_window

Novartis CEO sets aside $700 million to settle bribery lawsuit

Vas Narasimhan, Novartis’ CEO, has set aside $700 million to settle a bribery lawsuit in …

The Gateway to Local Adoption Series

Latest content